Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Steubl

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Clinical Chemistry and Laboratory Medicine|February 16, 2016
Plasma total C-terminal agrin fragment (tCAF) as a marker for kidney function in patients with chronic kidney diseaseDominik Steubl, Marcel Roos, Stefan Hettwer, et al.
Plos One|October 11, 2017
Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screeningSusanne Angermann, Marcus Baumann, Dominik Steubl, et al.
Journal of the American College of Cardiology|March 25, 2022
Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection FractionJoão Pedro Ferreira, Javed Butler, Faiez Zannad, et al.
Diabetes Care|April 26, 2022
Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical TrialsKatherine R Tuttle, Adeera Levin, Masaomi Nangaku, et al.
Medicine|March 11, 2016
Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease PatientsDominik Steubl, Matthias Block, Victor Herbst, et al.
Journal of the American College of Cardiology|March 19, 2021
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-ReducedJoão Pedro Ferreira, Faiez Zannad, Stuart J Pocock, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 24, 2019
Association of serum uromodulin with mortality and cardiovascular disease in the elderly-the Cardiovascular Health StudyDominik Steubl, Petra Buzkova, Pranav S Garimella, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 27, 2019
Association of Serum Uromodulin With ESKD and Kidney Function Decline in the Elderly: The Cardiovascular Health StudyDominik Steubl, Petra Buzkova, Pranav S Garimella, et al.
Scientific Reports|February 28, 2017
Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humansDominik Steubl, Santhosh V Kumar, Maia Tato, et al.
Medicine|May 25, 2019
Urinary uromodulin independently predicts end-stage renal disease and rapid kidney function decline in a cohort of chronic kidney disease patientsDominik Steubl, Matthias Block, Victor Herbst, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Clinical Chemistry and Laboratory Medicine|February 16, 2016
Plasma total C-terminal agrin fragment (tCAF) as a marker for kidney function in patients with chronic kidney diseaseDominik Steubl, Marcel Roos, Stefan Hettwer, et al.
Plos One|October 11, 2017
Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screeningSusanne Angermann, Marcus Baumann, Dominik Steubl, et al.
Journal of the American College of Cardiology|March 25, 2022
Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection FractionJoão Pedro Ferreira, Javed Butler, Faiez Zannad, et al.
Diabetes Care|April 26, 2022
Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical TrialsKatherine R Tuttle, Adeera Levin, Masaomi Nangaku, et al.
Medicine|March 11, 2016
Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease PatientsDominik Steubl, Matthias Block, Victor Herbst, et al.
Journal of the American College of Cardiology|March 19, 2021
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-ReducedJoão Pedro Ferreira, Faiez Zannad, Stuart J Pocock, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 24, 2019
Association of serum uromodulin with mortality and cardiovascular disease in the elderly-the Cardiovascular Health StudyDominik Steubl, Petra Buzkova, Pranav S Garimella, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 27, 2019
Association of Serum Uromodulin With ESKD and Kidney Function Decline in the Elderly: The Cardiovascular Health StudyDominik Steubl, Petra Buzkova, Pranav S Garimella, et al.
Scientific Reports|February 28, 2017
Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humansDominik Steubl, Santhosh V Kumar, Maia Tato, et al.
Medicine|May 25, 2019
Urinary uromodulin independently predicts end-stage renal disease and rapid kidney function decline in a cohort of chronic kidney disease patientsDominik Steubl, Matthias Block, Victor Herbst, et al.
Pageof 8